Compound Detail
CHEMBL4539651
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CO/C1=C\C(C)=C\[C@@H](C)[C@@H](O)[C@@H](C)C/C(C)=C/C=C/[C@H](OC)[C@@H]([C@@H](C)[C@@H](O)[C@H](C)[C@@]2(OC)CC[C@H](C)[C@@H](C(C)C)O2)OC1=O
Basic Information
| ChEMBL ID | CHEMBL4539651 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | HZCRBHGKBVMGBU-JRFVUCHVSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
10
Publications
0
Known Names
Molecular Properties
620.9
MW (Da)
6.38
ALogP
8
HBA
2
HBD
103.7
PSA (Ų)
0.30
QED
2
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 4.87
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| SMMC-7721 | IC50 | = | 13600.0 | nM | 4.87 | Cytotoxicity against human SMMC7721 cells assessed as reduction in cell viabilit... | 26933756 |
| BGC-823 | IC50 | = | 46940.0 | nM | 4.33 | Cytotoxicity against human BGC823 cells assessed as reduction in cell viability ... | 26933756 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 26933756 | 10.1021/acs.jnatprod.5b00827 | BGC-823 | 1 |
| 26933756 | 10.1021/acs.jnatprod.5b00827 | Caco-2 | 1 |
| 26933756 | 10.1021/acs.jnatprod.5b00827 | NCI-H460 | 1 |
| 26933756 | 10.1021/acs.jnatprod.5b00827 | SMMC-7721 | 1 |
| 26933756 | 10.1021/acs.jnatprod.5b00827 | Bacillus spizizenii | 1 |
| 26933756 | 10.1021/acs.jnatprod.5b00827 | Staphylococcus aureus | 1 |
| 26933756 | 10.1021/acs.jnatprod.5b00827 | Escherichia coli | 1 |
| 26933756 | 10.1021/acs.jnatprod.5b00827 | Candida albicans | 1 |
| 26933756 | 10.1021/acs.jnatprod.5b00827 | Candida parapsilosis | 1 |
| 26933756 | 10.1021/acs.jnatprod.5b00827 | Cryptococcus neoformans | 1 |
Data from ChEMBL 36 via Core Engine